Opportunity timeline

PostedJul 24, 2026
DeadlineSep 21, 2026

In plain English

The National Cancer Institute is looking for small businesses to develop innovative technologies for treating or diagnosing pediatric and rare cancers. They are offering Phase I awards to fund proof-of-concept research. Proposals are due by September 21, 2026.

About this opportunity

THIS EDIT IS TO POST AMENDMENT #2. AMENDMENT #2 IS TO remove the Data Management Sharing Plan requirement and all references under Sections

5.9 Management and Sharing of Research Data,

6.1 Evaluation Process, Evaluation of Data Management and Sharing Plan,

8.5 Technical Proposal Content (I) Scientific Data Sharing. The deadline for receipt of proposals remains unchanged at 5:00pm, September 21, 2026. All other terms and conditions of the solicitation remain unchanged. PLEASE SEE ATTACHED AMENDMENT #2 PDF. ORIGINAL SOLICITATION DESCRIPTION: The National Cancer Institute (NCI) invites small business concerns to submit research proposals under this Phase I Small Business Innovation Research…

Time remaining

Closes Sep 21, 2026

07Days
:
10Hours
:
22Min
:
54Sec

Bid details are gathered and summarized automatically. Please verify details at the original source.

Ref No.

BS-271B1C